Experts unite to end confusion in cancer trial measurements
NCT ID NCT03676010
First seen Jan 04, 2026 · Last updated May 25, 2026 · Updated 21 times
Summary
This study brings together 265 experts to create clear, standard definitions for key measurements used in cancer clinical trials, such as how long patients live without their cancer getting worse. Currently, different trials define these measurements in different ways, making it hard to compare results. The goal is to provide guidelines that all researchers can use, leading to more reliable and comparable findings in future cancer studies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Centre Georges François Leclerc
Dijon, France
-
Institut Bergonié
Bordeaux, 33076, France
-
Institut du Cancer de Montpellier
Montpellier, France
Conditions
Explore the condition pages connected to this study.